Mahatma Gandhi Cancer Hospital is one of the best hospitals in Visakhapatnam. As we are one of the Top Cancer Hospitals in Andhra Pradesh, it offers the most comprehensive array of healthcare services. Book Appointment now!
In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive results for the treatment of various types of cancer. For instance, the launch of Xofigo (Radium-223) by Bayer for the treatment of prostate cancer and the launch of Lutathera (Lutetium-177) for the treatment of neuroblastoma and synovitis has created growth opportunities for the therapeutic nuclear medicines market over the forecast period.
Most Advanced Prostate Cancer patients who have undergone Alpha PSMA Therapy have experienced a remarkable improvement in their quality of life with reduced symptoms and pain.
According to Straits Research, the global radioligand therapy market size was valued at USD 8.37 billion in 2024 and is projected to reach from USD 9.31 billion in 2025 to USD 17.09 billion by 2033, growing at a CAGR of 7.89% during the forecast period (2025-2033).https://straitsresearch.com/report/radioligand-therapy-market/request-sample
According to Straits Research, the global radioligand therapy market size was valued at USD 8.37 billion in 2024 and is projected to reach from USD 9.31 billion in 2025 to USD 17.09 billion by 2033, growing at a CAGR of 7.89% during the forecast period (2025-2033).https://straitsresearch.com/report/radioligand-therapy-market/request-sample